Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
20 yesterday
long term outcomes of ewing sarcoma of the foot and ankle
Original title: “Long-Term Outcomes of Ewing Sarcoma of the Foot and Ankle.”
primary malignant mesothelioma of the tunica vaginalis presenting as hydrocele imaging pitfalls
Original title: “Primary malignant mesothelioma of the tunica vaginalis presenting as hydrocele: imaging pitfalls.”
end of rarity the evolving burden of interstitial lung diseases in england trends from a national population based cohort study
Original title: “End of rarity: the evolving burden of interstitial lung diseases in England - trends from a national population-based cohort study.”
well differentiated smarcb1 deficient pancreatic malignancy with indolent liver metastases
Original title: “Well-differentiated SMARCB1-deficient Pancreatic Malignancy With Indolent Liver Metastases.”
gastric neuroendocrine tumours after prolonged proton pump inhibitor use
Original title: “Gastric neuroendocrine tumours after prolonged proton pump inhibitor use.”
progressive anterior opercular syndrome foix chavany marie syndrome in neurodegenerative disease a case series
Original title: “Progressive anterior opercular syndrome (Foix-Chavany-Marie syndrome) in neurodegenerative disease: a case series.”
tumor induced osteomalacia caused by a mandibular phosphaturic mesenchymal tumor misdiagnosed as giant cell reparative granuloma case report
Original title: “Tumor-induced osteomalacia caused by a mandibular phosphaturic mesenchymal tumor misdiagnosed as giant cell reparative granuloma: case report.”
response to comment on fibrinogen promotes acute myelogenous leukemia progression via mir 486 gpr153 axis
Original title: “Response to Comment on: "Fibrinogen promotes acute myelogenous leukemia progression via miR-486/GPR153 axis".”
gastrointestinal ultrasound in systemic sclerosis a scoping review of current evidence
Original title: “Gastrointestinal ultrasound in systemic sclerosis: A scoping review of current evidence.”
pushing the boundaries of knowledge in alpha 1 antitrypsin deficiency
Original title: “Pushing the Boundaries of Knowledge in Alpha-1 Antitrypsin Deficiency.”
cerebral schistosoma japonicum infection confirmed by histopathology and pcr diagnostic and therapeutic challenges in multiple parasitic coinfections
Original title: “Cerebral Schistosoma japonicum infection confirmed by histopathology and PCR: Diagnostic and therapeutic challenges in multiple parasitic coinfections.”
antimicrobial resistance profiles and genomic diversity of vaginal prevotella bivia isolates from south african women including the first report of nimk in south african vaginal p bivia isolates
Original title: “Antimicrobial resistance profiles and genomic diversity of vaginal Prevotella bivia isolates from South African women, including the first report of nimK in South African vaginal P. bivia isolates.”
large osseous choristoma of the tongue base a case report and literature review
Original title: “Large Osseous Choristoma of the Tongue Base: A Case Report and Literature Review.”
The Office of Refugee Resettlement (ORR) published a notice in the Federal Register of July 14, 2026, extending the eligibility time period for Refugee Cash Assistance (RCA) and Refugee Medical Assistance (RMA). After further review of the considerations listed 45 CFR 400.211, ORR determined that the eligibility period should be 12 months. This submission is to correct the time eligibility period to 12 months for both programs.
Original title: “Period for Refugee Cash Assistance and Refugee Medical Assistance; Correction”
insights into diagnosis and management of giant adrenal pseudocysts
Original title: “Insights into diagnosis and management of giant adrenal pseudocysts.”
intervention with a handmade closed loop balloon stent for a pulmonary artery fistula not closed by coil
Original title: “Intervention with a handmade closed-loop balloon stent for a pulmonary artery fistula not closed by coil.”
The Food and Drug Administration (FDA) is announcing the renewal of the Dermatologic and Ophthalmic Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Dermatologic and Ophthalmic Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the October 7, 2028, expiration date.
Original title: “Advisory Committee; Dermatologic and Ophthalmic Drugs Advisory Committee; Renewal”
In accordance with the National Institutes of Health (NIH), Tribal Consultation Policy, the NIH will hold two Tribal Consultations and one Tribal listening session at the National Congress of American Indians (NCAI) Annual Convention. The first consultation will discuss two new proposed initiatives of the NIH All of Us Research Program. The second consultation will discuss the National Institute of Minority Health and Health Disparities (NIMHD) proposed renewal initiative for the Resource Center
Original title: “Notice of NIH Tribal Consultations and Listening Session”
The Agency for Toxic Substances and Disease Registry (ATSDR), within the Department of Health and Human Services (HHS), announces the opening of a docket to obtain comments on a draft of the updated Toxicological Profiles for Cadmium and Hexachlorocyclopentadiene. This action provides an opportunity for the public and organizations to submit comments on drafts of the profiles. In particular, ATSDR is interested in any relevant additional information, data, research studies, or reports on the hea
Original title: “Availability of Two Draft Toxicological Profiles”
The Food and Drug Administration (FDA) is announcing the renewal of the Antimicrobial Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Antimicrobial Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the October 7, 2028, expiration date.
Original title: “Advisory Committee; Antimicrobial Drugs Advisory Committee; Renewal”